Review



ventricular septum  (Digitimer North America LLC)


Bioz Verified Symbol Digitimer North America LLC is a verified supplier
Bioz Manufacturer Symbol Digitimer North America LLC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Digitimer North America LLC ventricular septum
    MAP traces obtained from the epicardium of the left ventricle in WT and RyR2 S/S hearts during S1S2 pacing highlighting typical traces of either normal activity or arrhythmogenesis. All WT hearts entered the refractory period without displaying any episodes of arrhythmia, as defined by two or more non-stimulated APs ( a ); however, one heart displayed the occurrence of a singular ectopic (one non-stimulated AP) ( b ). Multiple arrhythmic events were observed in RyR2 S/S hearts including short non-sustained <t>ventricular</t> tachycardia (NSVT) ( c ), polymorphic tachycardia following a previously imposed S2 extrastimulus ( d ), monomorphic ventricular tachycardia (VT) ( e ) and episodes of VT which deteriorated into ventricular fibrillation (VF) (F). The small black circles indicate the timing of stimuli
    Ventricular Septum, supplied by Digitimer North America LLC, used in various techniques. Bioz Stars score: 96/100, based on 497 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ventricular septum/product/Digitimer North America LLC
    Average 96 stars, based on 497 article reviews
    ventricular septum - by Bioz Stars, 2026-05
    96/100 stars

    Images

    1) Product Images from "The RyR2-P2328S mutation downregulates Na v 1.5 producing arrhythmic substrate in murine ventricles"

    Article Title: The RyR2-P2328S mutation downregulates Na v 1.5 producing arrhythmic substrate in murine ventricles

    Journal: Pflugers Archiv

    doi: 10.1007/s00424-015-1750-0

    MAP traces obtained from the epicardium of the left ventricle in WT and RyR2 S/S hearts during S1S2 pacing highlighting typical traces of either normal activity or arrhythmogenesis. All WT hearts entered the refractory period without displaying any episodes of arrhythmia, as defined by two or more non-stimulated APs ( a ); however, one heart displayed the occurrence of a singular ectopic (one non-stimulated AP) ( b ). Multiple arrhythmic events were observed in RyR2 S/S hearts including short non-sustained ventricular tachycardia (NSVT) ( c ), polymorphic tachycardia following a previously imposed S2 extrastimulus ( d ), monomorphic ventricular tachycardia (VT) ( e ) and episodes of VT which deteriorated into ventricular fibrillation (VF) (F). The small black circles indicate the timing of stimuli
    Figure Legend Snippet: MAP traces obtained from the epicardium of the left ventricle in WT and RyR2 S/S hearts during S1S2 pacing highlighting typical traces of either normal activity or arrhythmogenesis. All WT hearts entered the refractory period without displaying any episodes of arrhythmia, as defined by two or more non-stimulated APs ( a ); however, one heart displayed the occurrence of a singular ectopic (one non-stimulated AP) ( b ). Multiple arrhythmic events were observed in RyR2 S/S hearts including short non-sustained ventricular tachycardia (NSVT) ( c ), polymorphic tachycardia following a previously imposed S2 extrastimulus ( d ), monomorphic ventricular tachycardia (VT) ( e ) and episodes of VT which deteriorated into ventricular fibrillation (VF) (F). The small black circles indicate the timing of stimuli

    Techniques Used: Activity Assay

    Typical MAP recordings obtained from the left ventricular epicardium of WT and RyR2 S/S during dynamic pacing. Traces from WT ( left ) and RyR2 S/S at progressively decreasing BCLs: 124 ( a ), 99 ( b ), 84 ( c ), 74 ( d ) and 54 ms ( e ). If a heart entered 2:1 block, the protocol was terminated (E). Traces are displayed along a common horizontal timescale. The vertical scale was normalized to a standard AP deflection at a BCL of 134 ms. Small black circles above each trace indicate the timing of stimuli
    Figure Legend Snippet: Typical MAP recordings obtained from the left ventricular epicardium of WT and RyR2 S/S during dynamic pacing. Traces from WT ( left ) and RyR2 S/S at progressively decreasing BCLs: 124 ( a ), 99 ( b ), 84 ( c ), 74 ( d ) and 54 ms ( e ). If a heart entered 2:1 block, the protocol was terminated (E). Traces are displayed along a common horizontal timescale. The vertical scale was normalized to a standard AP deflection at a BCL of 134 ms. Small black circles above each trace indicate the timing of stimuli

    Techniques Used: Blocking Assay

    Total Cx43 expression in WT and RyR2 S/S ventricles. a Representative blots of Cx43 and GAPDH expression in WT and RyR2 S/S ventricular tissue and b the mean (± SEM) Cx43 expression normalized to GAPDH expression. Cx43 expression was similar between WT and RyR2 S/S (0.59 ± 0.07 and 0.79 ± 0.1, respectively; P = 0.167, n = 4) ventricles
    Figure Legend Snippet: Total Cx43 expression in WT and RyR2 S/S ventricles. a Representative blots of Cx43 and GAPDH expression in WT and RyR2 S/S ventricular tissue and b the mean (± SEM) Cx43 expression normalized to GAPDH expression. Cx43 expression was similar between WT and RyR2 S/S (0.59 ± 0.07 and 0.79 ± 0.1, respectively; P = 0.167, n = 4) ventricles

    Techniques Used: Expressing

    Western blots of Na v 1.5 expression in whole tissue and membrane fraction samples from WT and RyR2 S/S ventricles. Ventricular Na v 1.5 expression was decreased in RyR2 S/S compared to WT, both in the whole tissue (1.17 ± 0.20; n = 6, vs 1.69 ± 0.15 n = 7, respectively, P = 0.048) and in the membrane fraction (0.91 ± 0.13; n = 4, vs 2.06 ± 0.33; n = 4, respectively, P = 0.006). This suggested a greater proportional reduction in membrane relative to total Na v 1.5 expression in RyR2 S/S . Symbols denote significant differences between genotypes * P < 0.05, ** P < 0.01
    Figure Legend Snippet: Western blots of Na v 1.5 expression in whole tissue and membrane fraction samples from WT and RyR2 S/S ventricles. Ventricular Na v 1.5 expression was decreased in RyR2 S/S compared to WT, both in the whole tissue (1.17 ± 0.20; n = 6, vs 1.69 ± 0.15 n = 7, respectively, P = 0.048) and in the membrane fraction (0.91 ± 0.13; n = 4, vs 2.06 ± 0.33; n = 4, respectively, P = 0.006). This suggested a greater proportional reduction in membrane relative to total Na v 1.5 expression in RyR2 S/S . Symbols denote significant differences between genotypes * P < 0.05, ** P < 0.01

    Techniques Used: Western Blot, Expressing, Membrane

    Loose patch clamp recordings of I Na activation in WT and RyR2 S/S ventricles. a Representative currents in response to depolarizing steps increased from 20 to 120 mV in voltage-clamped WT and RyR2 S/S ventricular tissue. b Peak inward current (mean ± SEM) elicited at each voltage step for WT ( n = 6) and RyR2 S/S ( n = 12) ventricles. c The maximum current recorded during each complete voltage step protocol (mean ± SEM) was larger in the WT than the RyR2 S/S ventricles, P < 0.0047. The asterisks denote significant differences between genotypes of P < 0.01
    Figure Legend Snippet: Loose patch clamp recordings of I Na activation in WT and RyR2 S/S ventricles. a Representative currents in response to depolarizing steps increased from 20 to 120 mV in voltage-clamped WT and RyR2 S/S ventricular tissue. b Peak inward current (mean ± SEM) elicited at each voltage step for WT ( n = 6) and RyR2 S/S ( n = 12) ventricles. c The maximum current recorded during each complete voltage step protocol (mean ± SEM) was larger in the WT than the RyR2 S/S ventricles, P < 0.0047. The asterisks denote significant differences between genotypes of P < 0.01

    Techniques Used: Patch Clamp, Activation Assay



    Similar Products

    90
    Cordis corporation ventricular septum (septum interventriculare cordis)
    Ventricular Septum (Septum Interventriculare Cordis), supplied by Cordis corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ventricular septum (septum interventriculare cordis)/product/Cordis corporation
    Average 90 stars, based on 1 article reviews
    ventricular septum (septum interventriculare cordis) - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Simulation Curriculum surgical simulation curriculum for ventricular septum defect closure
    Surgical Simulation Curriculum For Ventricular Septum Defect Closure, supplied by Simulation Curriculum, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/surgical simulation curriculum for ventricular septum defect closure/product/Simulation Curriculum
    Average 90 stars, based on 1 article reviews
    surgical simulation curriculum for ventricular septum defect closure - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Sagmeister Inc swiss cheese defect of the ventricular septum
    Swiss Cheese Defect Of The Ventricular Septum, supplied by Sagmeister Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/swiss cheese defect of the ventricular septum/product/Sagmeister Inc
    Average 90 stars, based on 1 article reviews
    swiss cheese defect of the ventricular septum - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    86
    St Jude Medical amplatzer muscular ventricular septum defect device
    Amplatzer Muscular Ventricular Septum Defect Device, supplied by St Jude Medical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/amplatzer muscular ventricular septum defect device/product/St Jude Medical
    Average 86 stars, based on 1 article reviews
    amplatzer muscular ventricular septum defect device - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    96
    AutoMate Scientific Inc ventricular septum
    Ventricular Septum, supplied by AutoMate Scientific Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ventricular septum/product/AutoMate Scientific Inc
    Average 96 stars, based on 1 article reviews
    ventricular septum - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    86
    Wolters Kluwer Health ventricular septum
    Ventricular Septum, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ventricular septum/product/Wolters Kluwer Health
    Average 86 stars, based on 1 article reviews
    ventricular septum - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    96
    Digitimer North America LLC ventricular septum
    MAP traces obtained from the epicardium of the left ventricle in WT and RyR2 S/S hearts during S1S2 pacing highlighting typical traces of either normal activity or arrhythmogenesis. All WT hearts entered the refractory period without displaying any episodes of arrhythmia, as defined by two or more non-stimulated APs ( a ); however, one heart displayed the occurrence of a singular ectopic (one non-stimulated AP) ( b ). Multiple arrhythmic events were observed in RyR2 S/S hearts including short non-sustained <t>ventricular</t> tachycardia (NSVT) ( c ), polymorphic tachycardia following a previously imposed S2 extrastimulus ( d ), monomorphic ventricular tachycardia (VT) ( e ) and episodes of VT which deteriorated into ventricular fibrillation (VF) (F). The small black circles indicate the timing of stimuli
    Ventricular Septum, supplied by Digitimer North America LLC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ventricular septum/product/Digitimer North America LLC
    Average 96 stars, based on 1 article reviews
    ventricular septum - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    Image Search Results


    MAP traces obtained from the epicardium of the left ventricle in WT and RyR2 S/S hearts during S1S2 pacing highlighting typical traces of either normal activity or arrhythmogenesis. All WT hearts entered the refractory period without displaying any episodes of arrhythmia, as defined by two or more non-stimulated APs ( a ); however, one heart displayed the occurrence of a singular ectopic (one non-stimulated AP) ( b ). Multiple arrhythmic events were observed in RyR2 S/S hearts including short non-sustained ventricular tachycardia (NSVT) ( c ), polymorphic tachycardia following a previously imposed S2 extrastimulus ( d ), monomorphic ventricular tachycardia (VT) ( e ) and episodes of VT which deteriorated into ventricular fibrillation (VF) (F). The small black circles indicate the timing of stimuli

    Journal: Pflugers Archiv

    Article Title: The RyR2-P2328S mutation downregulates Na v 1.5 producing arrhythmic substrate in murine ventricles

    doi: 10.1007/s00424-015-1750-0

    Figure Lengend Snippet: MAP traces obtained from the epicardium of the left ventricle in WT and RyR2 S/S hearts during S1S2 pacing highlighting typical traces of either normal activity or arrhythmogenesis. All WT hearts entered the refractory period without displaying any episodes of arrhythmia, as defined by two or more non-stimulated APs ( a ); however, one heart displayed the occurrence of a singular ectopic (one non-stimulated AP) ( b ). Multiple arrhythmic events were observed in RyR2 S/S hearts including short non-sustained ventricular tachycardia (NSVT) ( c ), polymorphic tachycardia following a previously imposed S2 extrastimulus ( d ), monomorphic ventricular tachycardia (VT) ( e ) and episodes of VT which deteriorated into ventricular fibrillation (VF) (F). The small black circles indicate the timing of stimuli

    Article Snippet: Hearts were paced at twice their excitation threshold voltage using a bipolar platinum-coated stimulating electrode placed on the ventricular septum connected to a DS2A-Mk.II stimulator (Digitimer).

    Techniques: Activity Assay

    Typical MAP recordings obtained from the left ventricular epicardium of WT and RyR2 S/S during dynamic pacing. Traces from WT ( left ) and RyR2 S/S at progressively decreasing BCLs: 124 ( a ), 99 ( b ), 84 ( c ), 74 ( d ) and 54 ms ( e ). If a heart entered 2:1 block, the protocol was terminated (E). Traces are displayed along a common horizontal timescale. The vertical scale was normalized to a standard AP deflection at a BCL of 134 ms. Small black circles above each trace indicate the timing of stimuli

    Journal: Pflugers Archiv

    Article Title: The RyR2-P2328S mutation downregulates Na v 1.5 producing arrhythmic substrate in murine ventricles

    doi: 10.1007/s00424-015-1750-0

    Figure Lengend Snippet: Typical MAP recordings obtained from the left ventricular epicardium of WT and RyR2 S/S during dynamic pacing. Traces from WT ( left ) and RyR2 S/S at progressively decreasing BCLs: 124 ( a ), 99 ( b ), 84 ( c ), 74 ( d ) and 54 ms ( e ). If a heart entered 2:1 block, the protocol was terminated (E). Traces are displayed along a common horizontal timescale. The vertical scale was normalized to a standard AP deflection at a BCL of 134 ms. Small black circles above each trace indicate the timing of stimuli

    Article Snippet: Hearts were paced at twice their excitation threshold voltage using a bipolar platinum-coated stimulating electrode placed on the ventricular septum connected to a DS2A-Mk.II stimulator (Digitimer).

    Techniques: Blocking Assay

    Total Cx43 expression in WT and RyR2 S/S ventricles. a Representative blots of Cx43 and GAPDH expression in WT and RyR2 S/S ventricular tissue and b the mean (± SEM) Cx43 expression normalized to GAPDH expression. Cx43 expression was similar between WT and RyR2 S/S (0.59 ± 0.07 and 0.79 ± 0.1, respectively; P = 0.167, n = 4) ventricles

    Journal: Pflugers Archiv

    Article Title: The RyR2-P2328S mutation downregulates Na v 1.5 producing arrhythmic substrate in murine ventricles

    doi: 10.1007/s00424-015-1750-0

    Figure Lengend Snippet: Total Cx43 expression in WT and RyR2 S/S ventricles. a Representative blots of Cx43 and GAPDH expression in WT and RyR2 S/S ventricular tissue and b the mean (± SEM) Cx43 expression normalized to GAPDH expression. Cx43 expression was similar between WT and RyR2 S/S (0.59 ± 0.07 and 0.79 ± 0.1, respectively; P = 0.167, n = 4) ventricles

    Article Snippet: Hearts were paced at twice their excitation threshold voltage using a bipolar platinum-coated stimulating electrode placed on the ventricular septum connected to a DS2A-Mk.II stimulator (Digitimer).

    Techniques: Expressing

    Western blots of Na v 1.5 expression in whole tissue and membrane fraction samples from WT and RyR2 S/S ventricles. Ventricular Na v 1.5 expression was decreased in RyR2 S/S compared to WT, both in the whole tissue (1.17 ± 0.20; n = 6, vs 1.69 ± 0.15 n = 7, respectively, P = 0.048) and in the membrane fraction (0.91 ± 0.13; n = 4, vs 2.06 ± 0.33; n = 4, respectively, P = 0.006). This suggested a greater proportional reduction in membrane relative to total Na v 1.5 expression in RyR2 S/S . Symbols denote significant differences between genotypes * P < 0.05, ** P < 0.01

    Journal: Pflugers Archiv

    Article Title: The RyR2-P2328S mutation downregulates Na v 1.5 producing arrhythmic substrate in murine ventricles

    doi: 10.1007/s00424-015-1750-0

    Figure Lengend Snippet: Western blots of Na v 1.5 expression in whole tissue and membrane fraction samples from WT and RyR2 S/S ventricles. Ventricular Na v 1.5 expression was decreased in RyR2 S/S compared to WT, both in the whole tissue (1.17 ± 0.20; n = 6, vs 1.69 ± 0.15 n = 7, respectively, P = 0.048) and in the membrane fraction (0.91 ± 0.13; n = 4, vs 2.06 ± 0.33; n = 4, respectively, P = 0.006). This suggested a greater proportional reduction in membrane relative to total Na v 1.5 expression in RyR2 S/S . Symbols denote significant differences between genotypes * P < 0.05, ** P < 0.01

    Article Snippet: Hearts were paced at twice their excitation threshold voltage using a bipolar platinum-coated stimulating electrode placed on the ventricular septum connected to a DS2A-Mk.II stimulator (Digitimer).

    Techniques: Western Blot, Expressing, Membrane

    Loose patch clamp recordings of I Na activation in WT and RyR2 S/S ventricles. a Representative currents in response to depolarizing steps increased from 20 to 120 mV in voltage-clamped WT and RyR2 S/S ventricular tissue. b Peak inward current (mean ± SEM) elicited at each voltage step for WT ( n = 6) and RyR2 S/S ( n = 12) ventricles. c The maximum current recorded during each complete voltage step protocol (mean ± SEM) was larger in the WT than the RyR2 S/S ventricles, P < 0.0047. The asterisks denote significant differences between genotypes of P < 0.01

    Journal: Pflugers Archiv

    Article Title: The RyR2-P2328S mutation downregulates Na v 1.5 producing arrhythmic substrate in murine ventricles

    doi: 10.1007/s00424-015-1750-0

    Figure Lengend Snippet: Loose patch clamp recordings of I Na activation in WT and RyR2 S/S ventricles. a Representative currents in response to depolarizing steps increased from 20 to 120 mV in voltage-clamped WT and RyR2 S/S ventricular tissue. b Peak inward current (mean ± SEM) elicited at each voltage step for WT ( n = 6) and RyR2 S/S ( n = 12) ventricles. c The maximum current recorded during each complete voltage step protocol (mean ± SEM) was larger in the WT than the RyR2 S/S ventricles, P < 0.0047. The asterisks denote significant differences between genotypes of P < 0.01

    Article Snippet: Hearts were paced at twice their excitation threshold voltage using a bipolar platinum-coated stimulating electrode placed on the ventricular septum connected to a DS2A-Mk.II stimulator (Digitimer).

    Techniques: Patch Clamp, Activation Assay